Industrifonden

Industrifonden, established in 1979, is a Swedish venture capital firm focused on early-stage investments in technology and life science companies with international potential. It invests in sectors such as internet and media, information technology, life sciences, and industrial growth, with a particular interest in deep tech, AI, and disruptive technologies. The firm typically invests between SEK 5 million to SEK 100 million per company, seeking ownership interests of between 15 to 50 percent. Industrifonden provides financing through equity capital and various types of loans and guarantees, often co-investing with other regional venture capital firms. It actively supports its portfolio companies, typically taking a board seat and working long-term with entrepreneurs. The firm exits its investments usually within five to ten years through sales to industry players or initial public offerings. Notable Industrifonden-backed companies include Qlik, Arcam, and CellaVision.

Per Anell

Senior Investment Director and Practice Lead Transformative Tech

Iliam Barkino

Principal

Tomas Bie

Investment Director

Karolina Bjurehed

Investment Director

Jonas Brambeck Ph.D

Senior Investment Director

Tobias Elmquist

Senior Investment Director

Tobias Elmquist

Senior Investment Director

Anna Haupt

Investment Director

Jonathan Ilicki MD

Principal

Anna Ljungdahl

Senior Investment Director

Caroline Murray

CFO

Patrik Sobocki

Senior Investment Director and Practice Lead Deep Tech

Andreas Söneby

Venture Partner

Tore Tolke

Senior Investment Director

Mala Valroy

Investment Manager

Caroline Wachtmeister

Principal

Peter Wolpert

CEO

Matti Zemack

Investment Director

Sara Frykstrand Ångström

Associate

Caroline Wadstein

Investor

211 past transactions

Tribune Therapeutics

Series A in 2025
Tribune Therapeutics is a preclinical biopharmaceutical company dedicated to advancing novel therapies for fibrotic diseases. They focus on developing innovative medicines targeting the CCN protein family, which plays a crucial role in fibrosis development. Their pipeline aims to address a broad spectrum of fibrotic conditions, offering potential new treatment options for patients.

Novatron

Series A in 2025
Novatron is focused on developing a proprietary fusion power concept aimed at producing clean, sustainable energy. Collaborating with physicists, engineers, and academic institutions, the company seeks to create an energy system that not only reduces reliance on fossil fuels but also minimizes greenhouse gas emissions. By advancing fusion energy technology, Novatron aims to provide abundant and renewable energy solutions, contributing to a more sustainable future for humanity.

GÃ¥rdsfisk

Series A in 2025
GÃ¥rdsfisk AB is a Swedish company founded in 2013 and headquartered in Ã…hus, specializing in innovative fish farming techniques. The company focuses on sustainable land-based aquaculture, utilizing large tanks in a closed system to cultivate fish. This method allows for the reuse of nutrient-rich wastewater as fertilizer, promoting environmentally friendly practices in agriculture. By developing technologies that enable farmers to breed fish without the adverse effects associated with traditional aquaculture, GÃ¥rdsfisk aims to provide a sustainable alternative for fish production. The company's approach not only enhances the farming portfolio for producers but also addresses the environmental challenges linked to conventional fish farming methods.

Echandia

Venture Round in 2025
Echandia specializes in developing advanced energy storage solutions and battery systems specifically for maritime transportation, shipping, and other heavy-duty applications. The company's product lineup includes LTO Battery Systems that utilize Lithium-Titanate-Oxide technology, known for their exceptional safety, rapid charging capabilities—fully charged in approximately 10 minutes—and an impressive lifespan exceeding 30,000 cycles. Additionally, Echandia offers the Echandia Energy system, an air-cooled lithium-ion battery designed for long-term maritime use, ensuring both safe and efficient operation. Furthermore, the Echandia Power system is engineered for hybrid applications, providing high power output for short durations, typically lasting five minutes or less per cycle. Through these innovative solutions, Echandia aims to promote zero-emission energy use in maritime, rail, and wind power sectors, enabling clients to adopt sustainable energy assets in their operations.

Fibbl

Venture Round in 2025
Fibbl is a pioneering visual marketing platform that specializes in 3D and augmented reality solutions. It offers a cost-effective, end-to-end system designed to seamlessly integrate 3D and AR technologies into e-commerce and marketing strategies. The company has industrialized the production of photorealistic 3D models for consumer products, supporting a diverse range of brands from various industries. Fibbl boasts the largest database of 3D models for consumer products, allowing businesses to implement these visual assets quickly and efficiently. With its innovative approach, Fibbl transforms how brands engage with customers by enhancing the online shopping experience through immersive visual content.

Senseworks

Venture Round in 2025
Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.

Agteria Biotech

Seed Round in 2025
Agteria Biotech is a biotech startup focused on developing sustainable agricultural solutions, particularly through innovative feed additives for livestock. Its distinctive products aim to enhance livestock health and well-being while simultaneously reducing methane emissions, contributing to a more sustainable livestock farming industry. By improving animal health, Agteria Biotech's offerings have the potential to increase productivity and decrease the reliance on antibiotics, thus supporting customers in their efforts to adopt more environmentally friendly farming practices.

Open Payments

Venture Round in 2025
Open Payments Europe is a developer of an innovative open banking platform that facilitates secure access to a wide range of bank APIs across Europe. Established in 2017 and headquartered in Stockholm, Sweden, the company provides crucial infrastructure for the open banking ecosystem, complying with PSD2 regulations. Its platform enables third-party providers and business partners to seamlessly integrate banking services while maintaining their own branding and user experience. By offering a single, secure access point, Open Payments empowers businesses to develop and enhance their products and services in a streamlined manner, promoting efficiency and innovation in financial technology.

Gesynta Pharma

Series B in 2025
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

AnaCardio

Series A in 2025
AnaCardio is a clinical stage biopharmaceutical company focused on developing innovative drugs for the treatment of heart failure. The company's therapeutics aim to enhance the contractility of the heart muscle through a unique mechanism that utilizes a therapeutic peptide. This approach is designed to avoid common adverse effects associated with traditional treatments, such as tachycardia, arrhythmia, ischemia, or hypotension. By improving cardiac output safely, AnaCardio's drugs have the potential to enhance organ function, elevate quality of life, increase functional capacity, and lower the risks of hospitalization and mortality for patients suffering from heart failure.

Avassa

Venture Round in 2024
Avassa is a company that specializes in managing applications across distributed edge locations. Its platform facilitates secure and remote updates, monitoring, and troubleshooting of edge applications on a large scale. By simplifying application orchestration and ensuring a zero-trust security model for all users and sites, Avassa helps businesses efficiently manage the lifecycle of their edge applications with speed and security. The company's solution is designed to bridge the gap between modern containerized application development and operations and distributed edge infrastructure, enabling teams to deploy, monitor, and observe workloads effectively in various environments.

Saltx Technology Holding

Post in 2024
SaltX Technology Holding AB specializes in the development and sale of innovative energy storage solutions. The company has created and patented a groundbreaking technology that enables the storage of energy in salt crystals. This unique approach allows for efficient conversion of stored energy into heating and cooling applications. By leveraging the properties of salt, SaltX aims to provide sustainable energy storage options that contribute to the future of energy management.

BOOST Pharma

Venture Round in 2024
BOOST Pharma is a biotechnology research company based in Copenhagen, Denmark, founded in 2019. The company specializes in developing a stem cell therapy aimed at treating osteogenesis imperfecta, a genetic disorder characterized by fragile bones. BOOST Pharma's innovative approach utilizes novel mesenchymal stem cells known for their strong bone-forming capabilities. Once injected into patients, these stem cells migrate to the bone, where they engraft and initiate the process of bone formation. This therapeutic strategy enables clinicians to address the disease at its earliest stages, potentially enhancing long-term outcomes for patients.

ZeroPoint Technologies

Series A in 2024
ZeroPoint Technologies specializes in innovative memory compression technology aimed at enhancing data center and smart device efficiency. By removing up to 70% of unnecessary information from microchips, the company enables significantly improved performance, achieving up to 50% more performance per watt. This technology combines ultra-fast data compression, real-time data compaction, and transparent memory management into a single solution, making it distinct in the industry. The company's products allow data centers to maximize performance while minimizing energy consumption, and enable smart device developers to enhance performance and user experience without sacrificing battery life. ZeroPoint's approach is founded on decades of research from a renowned academic group, supported by a robust patent portfolio and a continuous pipeline of innovative ideas. The company delivers hardware intellectual property blocks that clients can integrate into their systems on a chip (SoC) and collaborates closely with industry leaders on advanced technology projects.

Telness Tech

Convertible Note in 2024
Telness Tech provides cloud-based telecom solutions.

Arevo

Venture Round in 2024
Arevo specializes in the development of biostimulants and plant nutrition products, primarily focusing on the cultivation of forest plants such as pine and spruce. The company's innovative technologies include liquid and granular amino acid fertilizers that enhance plant establishment and growth. Arevo's specialized fertilizers not only promote improved growth but also significantly impact plant survival and carbon sequestration. By fostering robust root systems, their products help make plants more stress-resistant, thereby simplifying the cultivation process for producers.

Asgard Therapeutics

Series A in 2024
Asgard Therapeutics is a private biotechnology company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Founded as a spin-off from Lund University, the company employs its proprietary TrojanDC technology to initiate immune responses by leveraging the biological properties of professional antigen-presenting cells. With a commitment to creating personalized and efficient gene therapy products, Asgard Therapeutics aims to expand its pipeline of off-the-shelf cancer treatments, particularly for patients with cancers that are resistant to traditional therapies. By activating tailored anti-cancer immune defenses, the company seeks to offer new therapeutic options for individuals in need of effective cancer treatment alternatives.

Apica

Venture Round in 2024
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

TrusTrace

Series B in 2024
TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.

Texray

Venture Round in 2023
Texray AB specializes in the development of innovative radiation protection textiles designed specifically for medical practitioners who utilize X-rays during surgical procedures. The company has created a patented, woven material that possesses unique attenuating properties, ensuring effective protection against harmful radiation. This breathable fabric not only enhances safety for healthcare professionals but also allows them to perform their critical work with reduced radiation exposure. Through its commitment to safety and innovation, Texray aims to support medical professionals in their efforts to save lives without compromising their health.

MinervaX

Venture Round in 2023
MinervaX is a biotechnology company focused on developing maternal vaccines to prevent infections caused by Group B streptococcus (GBS), which can lead to serious adverse pregnancy outcomes and life-threatening conditions for newborns. The company leverages a specific fusion protein that has shown promise in eliciting protective immunity against various clinically relevant GBS strains. By concentrating on this innovative vaccine approach, MinervaX aims to provide medical professionals with effective tools to safeguard newborns from bacterial infections, ultimately enhancing maternal and infant health outcomes.

Fast Travel Games

Venture Round in 2023
Fast Travel Games, established in 2016 and based in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their games are designed to be played socially, supported by VR headsets, and are characterized by deep, engaging game universes.

Cellevate

Seed Round in 2023
Cellevate AB, founded in 2014 and based in Lund, Sweden, is an innovative biotech company specializing in the development of advanced cell culture systems. The company's flagship product, 3D NanoMatrix, consists of nanofiber scaffolds designed to serve as realistic in-vitro models for scientific research and development across various industries including automotive, construction, defense, electronics, energy, environment, and healthcare. These nanofiber scaffolds are created through a patented manufacturing process that produces porous and consistent networks of nanofibers, enhancing the realism of cell culture systems used in upstream bioprocessing.

Pixelgen Technologies

Series A in 2023
Pixelgen Technologies is a company focused on advancing biomedical research and diagnostics through the development of innovative bio-analytical tools. Founded in 2020 and based in Sweden, Pixelgen Technologies creates novel analytical methods and products that provide researchers and drug developers with insights into the complexities of biological processes. By enhancing the understanding of biomedicine, the company aims to support improvements in health and contribute to the advancement of medical science.

AlixLabs

Seed Round in 2023
AlixLabs specializes in nanostructure fabrication utilizing atomic layer etching (ALE) technology, which enables the production of nanostructures with sizes smaller than 20 nanometers. This damage-free etching process surpasses the resolution limits of traditional optical and electron beam lithography, making it suitable for advanced applications in nanoelectronics. AlixLabs focuses on providing innovative manufacturing techniques that allow for precise and efficient creation of extremely small structures without the need for complex nano-patterning methods. By enhancing the capabilities of semiconductor manufacturing, AlixLabs contributes to the advancement of transistor technology, particularly for sub-20 nm technology nodes.

Novatron

Seed Round in 2023
Novatron is focused on developing a proprietary fusion power concept aimed at producing clean, sustainable energy. Collaborating with physicists, engineers, and academic institutions, the company seeks to create an energy system that not only reduces reliance on fossil fuels but also minimizes greenhouse gas emissions. By advancing fusion energy technology, Novatron aims to provide abundant and renewable energy solutions, contributing to a more sustainable future for humanity.

Apica

Venture Round in 2023
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

Fishbrain

Venture Round in 2023
FishBrain AB, established in 2009 and headquartered in Stockholm, Sweden, develops a mobile application that serves as a social network, commerce platform, and tool for sport fishing enthusiasts. The Fishbrain app connects anglers, enables users to track and share personal statistics, provides fishing forecasts, and offers an interactive map to discover new fishing spots and see real-time catch data. It also promotes responsible fishing practices, such as catch and release, and sustainable harvesting. The app is available on both the App Store and Google Play.

Virkesbörsen

Venture Round in 2023
Virkesbörsen is a Swedish company that operates a digital marketplace, facilitating the buying and selling of wood between suppliers and buyers.

Hopsworks

Series B in 2023
Hopsworks, founded in 2016 and headquartered in Stockholm, Sweden, is a developer of a comprehensive data platform that facilitates the management of data and artificial intelligence applications. The company specializes in providing Hopsworks Enterprise, an on-premise data management and data science platform that integrates deep learning, machine learning, and stream processing capabilities. Hopsworks focuses on building a Python-centric feature store that enables the creation and management of feature, training, and inference pipelines at scale. The platform is designed to support diverse data teams and sources, offering tools that enhance business growth through the application of AI technology to complex challenges. Hopsworks aims to deliver maximum performance and availability for organizations seeking to leverage data-intensive solutions.

Soundtrack Your Brand

Venture Round in 2023
Soundtrack Your Brand is a business-to-business music platform that enables small business owners to create and legally play personalized playlists in their venues. The company offers a subscription-based service that provides access to a vast commercial catalog of songs, allowing businesses to play any music they choose. This service ensures compliance with music licensing regulations while helping businesses enhance their digital media presence through curated soundtracks. By offering unlimited and customizable playlists, Soundtrack Your Brand caters to various business settings and events, ensuring an enjoyable experience for both customers and employees.

Retein

Venture Round in 2023
Retein is a water purification technology company focused on producing pure water at low energy costs. The firm utilizes advanced material recovery technology, specifically employing aquaporin proteins, to effectively remove pollutants such as microplastics and pharmaceutical residues from water. This innovative approach not only ensures the purification of water but also facilitates the sustainable recovery of valuable resources, promoting efficiency and cost-effectiveness for its clients. Retein aims to contribute to a resource-efficient and sustainable world through its cutting-edge solutions.

Open Payments

Venture Round in 2023
Open Payments Europe is a developer of an innovative open banking platform that facilitates secure access to a wide range of bank APIs across Europe. Established in 2017 and headquartered in Stockholm, Sweden, the company provides crucial infrastructure for the open banking ecosystem, complying with PSD2 regulations. Its platform enables third-party providers and business partners to seamlessly integrate banking services while maintaining their own branding and user experience. By offering a single, secure access point, Open Payments empowers businesses to develop and enhance their products and services in a streamlined manner, promoting efficiency and innovation in financial technology.

Teitur Trophics

Series A in 2023
Teitur Trophics is a biotech company established in 2020 and based in Aarhus, Denmark. The company specializes in the development of circular peptides aimed at addressing neurodegenerative diseases. Its research focuses on small peptides that interact with receptors central to neural function. By gaining insights into the biology of these receptors, Teitur Trophics aims to modulate key mechanisms in neural function, which may facilitate the creation of innovative treatments. These treatments are designed to be administered through daily injections, with the potential to prevent the onset of neurodegenerative conditions.

ZeroPoint Technologies

Seed Round in 2023
ZeroPoint Technologies specializes in innovative memory compression technology aimed at enhancing data center and smart device efficiency. By removing up to 70% of unnecessary information from microchips, the company enables significantly improved performance, achieving up to 50% more performance per watt. This technology combines ultra-fast data compression, real-time data compaction, and transparent memory management into a single solution, making it distinct in the industry. The company's products allow data centers to maximize performance while minimizing energy consumption, and enable smart device developers to enhance performance and user experience without sacrificing battery life. ZeroPoint's approach is founded on decades of research from a renowned academic group, supported by a robust patent portfolio and a continuous pipeline of innovative ideas. The company delivers hardware intellectual property blocks that clients can integrate into their systems on a chip (SoC) and collaborates closely with industry leaders on advanced technology projects.

Viking Analytics

Series A in 2023
Viking Analytics AB is a software development company based in Gothenburg, Sweden, that specializes in analytics solutions for the manufacturing, chemical, and process industries. Established in 2012, the company offers its flagship product, MultiViz, which enables industrial clients to prepare, analyze, and visualize sensor data and condition monitoring information. This advanced software enhances machine failure analysis and prediction, allowing users to identify potential issues and operational inefficiencies with greater accuracy than traditional methods. By facilitating effective remote monitoring, Viking Analytics helps maintenance firms, OEMs, and system integrators reduce unplanned maintenance breaks and optimize processes and energy use, all while minimizing false alarms and eliminating the need for dedicated AI teams.

EnginZyme

Series B in 2022
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. It specializes in biocatalysis and cell-free synthetic biology, providing sustainable alternatives to traditional materials such as plastics, nylons, and rubbers. EnginZyme's innovative platform utilizes enzymes to facilitate the green manufacturing of products essential to various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By replacing fossil-based manufacturing processes with its patented cell-free technology, the company aims to contribute to climate change mitigation and promote sustainable biomanufacturing practices. EnginZyme has garnered recognition as a Global Cleantech 100 company and has been acknowledged as a Technology Pioneer by the World Economic Forum, underscoring its commitment to advancing green chemistry across multiple sectors.

MinervaX

Series C in 2022
MinervaX is a biotechnology company focused on developing maternal vaccines to prevent infections caused by Group B streptococcus (GBS), which can lead to serious adverse pregnancy outcomes and life-threatening conditions for newborns. The company leverages a specific fusion protein that has shown promise in eliciting protective immunity against various clinically relevant GBS strains. By concentrating on this innovative vaccine approach, MinervaX aims to provide medical professionals with effective tools to safeguard newborns from bacterial infections, ultimately enhancing maternal and infant health outcomes.

Digip

Seed Round in 2022
Digip is a Swedish legal technology SaaS company that specializes in affordable and accessible trademark protection. It combines technological innovation with intellectual property expertise to streamline processes and reduce costs for customers seeking to protect their trademarks. Digip's software enables on-demand trademark registration, infringement protection, domain management, and global brand name protection in a user-friendly digital environment.

Occtoo

Seed Round in 2022
Occtoo AB is a software-as-a-service company headquartered in Vellinge, Sweden, that specializes in an Experience Data Platform tailored for retailers and brands. Founded in 2019, Occtoo enables digital teams to rapidly develop applications and digital experiences by transforming enterprise data into actionable experience data. The platform facilitates seamless access to customer experience data without the need for complex integrations, allowing users to efficiently match content with customers and create dynamic applications. Key features include content personalization, dynamic product profiling, brand shops, customer insights, and headless personalization. Occtoo's innovative technology is utilized by various notable brands, enhancing their ability to deliver personalized user experiences across multiple channels and touchpoints.

KISAB

Venture Round in 2022
KISAB is a partner of Mitronic IT services and is their local provider of office equipment and IT in technical service and sales. They offer sales, service, repairs, and accessories for most brands on the market, including Brother, Canon, Sharp, Olivetti, OKI, Lexmark, HP, Microsoft, and more.

AnaCardio

Series A in 2022
AnaCardio is a clinical stage biopharmaceutical company focused on developing innovative drugs for the treatment of heart failure. The company's therapeutics aim to enhance the contractility of the heart muscle through a unique mechanism that utilizes a therapeutic peptide. This approach is designed to avoid common adverse effects associated with traditional treatments, such as tachycardia, arrhythmia, ischemia, or hypotension. By improving cardiac output safely, AnaCardio's drugs have the potential to enhance organ function, elevate quality of life, increase functional capacity, and lower the risks of hospitalization and mortality for patients suffering from heart failure.

Airsonett

Venture Round in 2022
Airsonett is a medical device company focused on developing non-pharmaceutical treatments for allergic asthma and eczema. Its flagship product, the Air4, employs patented Temperature-controlled Laminar Airflow (TLA) technology to create a cleaner breathing environment. This non-invasive home device effectively reduces allergens and airborne irritants in the patient's vicinity during rest and sleep, providing significant relief for individuals suffering from allergic asthma and atopic eczema. Operating primarily in Sweden and the UK, Airsonett aims to enhance the quality of life for patients by offering effective prophylactic treatments that minimize reliance on traditional asthma medications.

Telness Tech

Series A in 2022
Telness Tech provides cloud-based telecom solutions.

Nextory

Venture Round in 2022
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

Elypta

Series A in 2022
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, founded in 2017. The company is focused on developing a metabolism-based liquid biopsy platform that aids in the early detection and monitoring of cancer. This platform employs a novel in vitro diagnostic laboratory assay kit and artificial intelligence algorithms, which analyze biomarkers in blood and urine to identify cancer signatures. Elypta's technology offers comprehensive profiling of glycosaminoglycan metabolites and includes scoring software to support a wide range of cancer applications, from screening to treatment response monitoring. The company is currently conducting clinical trials, particularly the AURORAX series, to investigate its platform's efficacy in renal cell carcinoma and other cancer indications, aiming to reduce cancer mortality through timely intervention.

ShardSecure

Series A in 2022
ShardSecure, Inc. is a data protection company that specializes in encryption and cloud data security software solutions. Founded in 2019 and headquartered in New York, the company employs its innovative Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology works by breaking data into small fragments, which are then distributed across multiple cloud platforms and interspersed with false shards. This approach makes it exceedingly difficult for cybercriminals to reconstruct the original data, thereby safeguarding it against unauthorized access. ShardSecure's solutions are application-agnostic and function as a virtual storage appliance, providing an additional layer of defense against potential misconfigurations in cloud environments. The company integrates seamlessly with major cloud service providers, including AWS, Azure, Google, and IBM, offering a simplified and effective alternative for enterprises and government agencies seeking robust data security solutions.

Peafowl Plasmonics

Seed Round in 2022
Peafowl Plasmonics is a company focused on innovative solar cell technology that emphasizes efficiency, affordability, and sustainability. The firm has developed highly transparent plasmonic solar cells capable of absorbing light in various conditions, including harsh outdoor environments and low-illumination indoor settings. This versatility allows for the seamless integration of sensors directly into window glass, eliminating the need for wires or batteries. By enabling commercial partners and customers to reduce energy consumption and lower carbon emissions, Peafowl Plasmonics contributes to efforts aimed at minimizing corporate carbon footprints.

Asgard Therapeutics

Seed Round in 2021
Asgard Therapeutics is a private biotechnology company focused on developing innovative cancer immunotherapies through direct cell reprogramming technologies. Founded as a spin-off from Lund University, the company employs its proprietary TrojanDC technology to initiate immune responses by leveraging the biological properties of professional antigen-presenting cells. With a commitment to creating personalized and efficient gene therapy products, Asgard Therapeutics aims to expand its pipeline of off-the-shelf cancer treatments, particularly for patients with cancers that are resistant to traditional therapies. By activating tailored anti-cancer immune defenses, the company seeks to offer new therapeutic options for individuals in need of effective cancer treatment alternatives.

TrusTrace

Series A in 2021
TrusTrace is a software company based in Stockholm, Sweden, with an additional location in Coimbatore, India, that specializes in traceability as a service for the fashion supply chain. Founded in 2016, TrusTrace offers a comprehensive platform that enables global brands and suppliers to capture, digitize, and share supply chain and material traceability data efficiently. Its suite of tools includes T-Tracem for end-to-end product traceability, T-CET for customer engagement, I-CAT for climate action management, and T-VeM for vendor management, among others. The platform consolidates validated supply chain data, allowing brands to substantiate product claims and ensure regulatory compliance while managing their environmental impact. By providing a single platform for traceability, TrusTrace empowers brands to enhance transparency and trust in their supply chains.

Funnel

Series C in 2021
Funnel is a software company that specializes in marketing analytics and reporting tools designed to streamline data collection for online advertisers and e-commerce businesses. Founded in 2014 by Fredrik Skantze and Per Made, the company is headquartered in Stockholm and has an office in Boston. Funnel offers a platform that integrates seamlessly with over 400 marketing and advertising data sources, enabling users to automate the collection and organization of their advertising performance data. This integration allows businesses to easily transfer their data into various tools, such as Business Intelligence platforms, Data Warehouses, Google Sheets, and visualization tools. By providing a comprehensive overview of advertising expenditures and performance, Funnel helps businesses, including e-commerce companies, media agencies, B2B enterprises, mobile applications, and gaming firms, make informed decisions and predict future growth.

ZeroPoint Technologies

Seed Round in 2021
ZeroPoint Technologies specializes in innovative memory compression technology aimed at enhancing data center and smart device efficiency. By removing up to 70% of unnecessary information from microchips, the company enables significantly improved performance, achieving up to 50% more performance per watt. This technology combines ultra-fast data compression, real-time data compaction, and transparent memory management into a single solution, making it distinct in the industry. The company's products allow data centers to maximize performance while minimizing energy consumption, and enable smart device developers to enhance performance and user experience without sacrificing battery life. ZeroPoint's approach is founded on decades of research from a renowned academic group, supported by a robust patent portfolio and a continuous pipeline of innovative ideas. The company delivers hardware intellectual property blocks that clients can integrate into their systems on a chip (SoC) and collaborates closely with industry leaders on advanced technology projects.

Limina Investment Management Solution

Series A in 2021
Limina Investment Management Solution (IMS) is a Front-to-Middle Office Solution that let investment managers focus on what matters: producing investment returns with minimal operational risk. The open platform help Asset Managers overcome fragmented workflows and increase confidence in data and oversight. Limina was founded by former investment managers that set out to create a solution to the challenges they faced. The solution now offered by Limina is engineered in Sweden and delivered by industry experts globally.

Hopsworks

Series A in 2021
Hopsworks, founded in 2016 and headquartered in Stockholm, Sweden, is a developer of a comprehensive data platform that facilitates the management of data and artificial intelligence applications. The company specializes in providing Hopsworks Enterprise, an on-premise data management and data science platform that integrates deep learning, machine learning, and stream processing capabilities. Hopsworks focuses on building a Python-centric feature store that enables the creation and management of feature, training, and inference pipelines at scale. The platform is designed to support diverse data teams and sources, offering tools that enhance business growth through the application of AI technology to complex challenges. Hopsworks aims to deliver maximum performance and availability for organizations seeking to leverage data-intensive solutions.

ShardSecure

Seed Round in 2021
ShardSecure, Inc. is a data protection company that specializes in encryption and cloud data security software solutions. Founded in 2019 and headquartered in New York, the company employs its innovative Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology works by breaking data into small fragments, which are then distributed across multiple cloud platforms and interspersed with false shards. This approach makes it exceedingly difficult for cybercriminals to reconstruct the original data, thereby safeguarding it against unauthorized access. ShardSecure's solutions are application-agnostic and function as a virtual storage appliance, providing an additional layer of defense against potential misconfigurations in cloud environments. The company integrates seamlessly with major cloud service providers, including AWS, Azure, Google, and IBM, offering a simplified and effective alternative for enterprises and government agencies seeking robust data security solutions.

Fast Travel Games

Series B in 2021
Fast Travel Games, established in 2016 and based in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their games are designed to be played socially, supported by VR headsets, and are characterized by deep, engaging game universes.

Digip

Seed Round in 2021
Digip is a Swedish legal technology SaaS company that specializes in affordable and accessible trademark protection. It combines technological innovation with intellectual property expertise to streamline processes and reduce costs for customers seeking to protect their trademarks. Digip's software enables on-demand trademark registration, infringement protection, domain management, and global brand name protection in a user-friendly digital environment.

NuvoAir Medical

Series A in 2021
NuvoAir AB, established in 2015 and headquartered in Stockholm, Sweden, specializes in remote patient monitoring for chronic heart and lung conditions. The company's core product is Air Next, a home spirometer that tracks lung function. NuvoAir's innovative platform combines this advanced monitoring technology with personalized care from a multidisciplinary team, including pulmonologists and cardiologists. By collaborating with health plans and risk-bearing entities, NuvoAir offers a value-based care model that aims to reduce healthcare costs and improve patient outcomes.

Exeri

Venture Round in 2021
Exeri AB is a Swedish company based in Luleå, established in 2009, that specializes in developing Smart Grid Surveillance technology. This innovative system digitizes electric grid networks, transforming them into smart grids that enhance monitoring and operational efficiency. Exeri's technology provides real-time insights into the electricity network, enabling network owners to detect problems promptly and improve overall security. By utilizing IoT technology and AI-based algorithms, Exeri's system offers precise error localization, predictive maintenance capabilities, and decision support. This advancement not only facilitates the integration of renewable energy sources but also supports the infrastructure required for electric vehicle charging, contributing to the reduction of fossil fuel dependency in various industries.

Lexly

Venture Round in 2021
Lexly is a leading provider of online legal services in the Nordic legal tech market. The company specializes in offering accessible legal advice on matters such as wills, gift deeds, and stockholder agreements. Lexly also features an online legal tool that enables individuals to create their own legal documents, thereby helping customers reduce legal costs and enhance efficiency. The group includes the brands Stirling Blue and Pactumize, further strengthening its position in the industry.

Meniga

Venture Round in 2021
Meniga Ltd is a London-based company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management for banks, businesses, and individuals. Established in 2013, Meniga offers a comprehensive suite of products, including data aggregation, automated real-time notifications, predictive analytics, and personalized engagement tools. Its platform is designed to provide meaningful customer interactions and unlock new revenue opportunities through advanced data consolidation and enrichment. Additionally, Meniga facilitates cashback rewards and transaction-based carbon insights, allowing users to manage financial data efficiently while promoting sustainability. The company's modular and customizable solutions cater to the diverse needs of financial institutions, reinforcing their customer relationships and improving the overall online and mobile banking experience.

Crosser

Venture Round in 2021
Crosser is a technology company that specializes in streaming analytics and integration software, catering to edge, fog, and cloud computing environments. Its platform enables real-time processing of both streaming and batch data, facilitating data transformation, analytics, automation, and integration. By providing real-time analytics and decision-making capabilities akin to those of IoT sensors and devices, Crosser empowers enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This functionality helps organizations minimize costs associated with cloud services and bandwidth, enhancing operational efficiency across various applications.

EnginZyme

Series A in 2021
EnginZyme AB is a biotechnology company based in Stockholm, Sweden, founded in 2014. It specializes in biocatalysis and cell-free synthetic biology, providing sustainable alternatives to traditional materials such as plastics, nylons, and rubbers. EnginZyme's innovative platform utilizes enzymes to facilitate the green manufacturing of products essential to various industries, including pharmaceuticals, food, chemicals, flavors, and fragrances. By replacing fossil-based manufacturing processes with its patented cell-free technology, the company aims to contribute to climate change mitigation and promote sustainable biomanufacturing practices. EnginZyme has garnered recognition as a Global Cleantech 100 company and has been acknowledged as a Technology Pioneer by the World Economic Forum, underscoring its commitment to advancing green chemistry across multiple sectors.

Occtoo

Seed Round in 2021
Occtoo AB is a software-as-a-service company headquartered in Vellinge, Sweden, that specializes in an Experience Data Platform tailored for retailers and brands. Founded in 2019, Occtoo enables digital teams to rapidly develop applications and digital experiences by transforming enterprise data into actionable experience data. The platform facilitates seamless access to customer experience data without the need for complex integrations, allowing users to efficiently match content with customers and create dynamic applications. Key features include content personalization, dynamic product profiling, brand shops, customer insights, and headless personalization. Occtoo's innovative technology is utilized by various notable brands, enhancing their ability to deliver personalized user experiences across multiple channels and touchpoints.

MinervaX

Series B in 2020
MinervaX is a biotechnology company focused on developing maternal vaccines to prevent infections caused by Group B streptococcus (GBS), which can lead to serious adverse pregnancy outcomes and life-threatening conditions for newborns. The company leverages a specific fusion protein that has shown promise in eliciting protective immunity against various clinically relevant GBS strains. By concentrating on this innovative vaccine approach, MinervaX aims to provide medical professionals with effective tools to safeguard newborns from bacterial infections, ultimately enhancing maternal and infant health outcomes.

Avassa

Funding Round in 2020
Avassa is a company that specializes in managing applications across distributed edge locations. Its platform facilitates secure and remote updates, monitoring, and troubleshooting of edge applications on a large scale. By simplifying application orchestration and ensuring a zero-trust security model for all users and sites, Avassa helps businesses efficiently manage the lifecycle of their edge applications with speed and security. The company's solution is designed to bridge the gap between modern containerized application development and operations and distributed edge infrastructure, enabling teams to deploy, monitor, and observe workloads effectively in various environments.

InRiver

Venture Round in 2020
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Open Payments

Seed Round in 2020
Open Payments Europe is a developer of an innovative open banking platform that facilitates secure access to a wide range of bank APIs across Europe. Established in 2017 and headquartered in Stockholm, Sweden, the company provides crucial infrastructure for the open banking ecosystem, complying with PSD2 regulations. Its platform enables third-party providers and business partners to seamlessly integrate banking services while maintaining their own branding and user experience. By offering a single, secure access point, Open Payments empowers businesses to develop and enhance their products and services in a streamlined manner, promoting efficiency and innovation in financial technology.

Gesynta Pharma

Series C in 2020
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

Meniga

Corporate Round in 2020
Meniga Ltd is a London-based company that specializes in developing white-label digital banking solutions aimed at enhancing personal finance management for banks, businesses, and individuals. Established in 2013, Meniga offers a comprehensive suite of products, including data aggregation, automated real-time notifications, predictive analytics, and personalized engagement tools. Its platform is designed to provide meaningful customer interactions and unlock new revenue opportunities through advanced data consolidation and enrichment. Additionally, Meniga facilitates cashback rewards and transaction-based carbon insights, allowing users to manage financial data efficiently while promoting sustainability. The company's modular and customizable solutions cater to the diverse needs of financial institutions, reinforcing their customer relationships and improving the overall online and mobile banking experience.

Trialbee

Venture Round in 2020
Trialbee AB is an independent software company based in Malmö, Sweden, established in 2010. It specializes in developing a software-as-a-service solution aimed at enhancing patient matching and engagement in clinical trials. The company's platform facilitates patient recruitment, enrollment, and retention by providing various services such as resource libraries, adherence reminders, and comprehensive patient journey management. Trialbee's technology enables candidates to search for clinical trials and offers pre-screening and analysis tools, thus simplifying the clinical research process. The company serves a range of clients, including pharmaceutical sponsors, contract research organizations (CROs), investigator sites, and patients, with the goal of accelerating drug development through improved recruitment accuracy and efficiency.

DbVis Software

Venture Round in 2020
DbVis Software AB, founded in 2003 and headquartered in Stockholm, Sweden, specializes in developing database management and analysis software. Its flagship product, DbVisualizer, serves as a platform-independent tool that supports connections to various data sources and enables users to manage database-specific objects, create and edit procedures, functions, and triggers, and perform schema exports and comparisons of editors and result sets. The company emphasizes a user-centric development approach, incorporating feedback from its community to ensure that new features enhance the software without unnecessary complexity. DbVis Software is committed to providing high-quality support directly from its development team, maintaining a transparent and competitive pricing model, which includes a free version and discounts for educational and non-profit institutions. With over 6 million downloads and more than 28,000 organizations in 145 countries using its commercial Pro version, DbVis Software has established itself as a trusted provider in the database management sector.

Nextory

Venture Round in 2020
Nextory AB is a Swedish company based in Kista that operates a mobile application offering a subscription service for access to a wide range of e-books and audiobooks. The platform allows users to download and listen to stories in both PDF and audio formats, providing a comprehensive digital library that enhances the reading experience. By enabling clients to explore a diverse catalog of literary content, Nextory aims to make reading more accessible and enjoyable through the convenience of smartphones and tablets.

Barnebys

Venture Round in 2020
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Elypta

Seed Round in 2020
Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, founded in 2017. The company is focused on developing a metabolism-based liquid biopsy platform that aids in the early detection and monitoring of cancer. This platform employs a novel in vitro diagnostic laboratory assay kit and artificial intelligence algorithms, which analyze biomarkers in blood and urine to identify cancer signatures. Elypta's technology offers comprehensive profiling of glycosaminoglycan metabolites and includes scoring software to support a wide range of cancer applications, from screening to treatment response monitoring. The company is currently conducting clinical trials, particularly the AURORAX series, to investigate its platform's efficacy in renal cell carcinoma and other cancer indications, aiming to reduce cancer mortality through timely intervention.

Funnel

Series B in 2020
Funnel is a software company that specializes in marketing analytics and reporting tools designed to streamline data collection for online advertisers and e-commerce businesses. Founded in 2014 by Fredrik Skantze and Per Made, the company is headquartered in Stockholm and has an office in Boston. Funnel offers a platform that integrates seamlessly with over 400 marketing and advertising data sources, enabling users to automate the collection and organization of their advertising performance data. This integration allows businesses to easily transfer their data into various tools, such as Business Intelligence platforms, Data Warehouses, Google Sheets, and visualization tools. By providing a comprehensive overview of advertising expenditures and performance, Funnel helps businesses, including e-commerce companies, media agencies, B2B enterprises, mobile applications, and gaming firms, make informed decisions and predict future growth.

ShardSecure

Seed Round in 2019
ShardSecure, Inc. is a data protection company that specializes in encryption and cloud data security software solutions. Founded in 2019 and headquartered in New York, the company employs its innovative Microshard technology to enhance the security of sensitive data stored and shared in the cloud. This technology works by breaking data into small fragments, which are then distributed across multiple cloud platforms and interspersed with false shards. This approach makes it exceedingly difficult for cybercriminals to reconstruct the original data, thereby safeguarding it against unauthorized access. ShardSecure's solutions are application-agnostic and function as a virtual storage appliance, providing an additional layer of defense against potential misconfigurations in cloud environments. The company integrates seamlessly with major cloud service providers, including AWS, Azure, Google, and IBM, offering a simplified and effective alternative for enterprises and government agencies seeking robust data security solutions.

Combinostics

Series A in 2019
Combinostics Oy, established in 2014 and based in Tampere, Finland, specializes in developing and marketing advanced software tools for data-driven diagnostics in neurodegenerative diseases. The company's core offering is a cloud-based platform that provides clinical decision support, enabling healthcare professionals to analyze brain images (MR, PET, CT) and make early, informed diagnoses, ultimately enhancing treatment outcomes.

Freemelt

Seed Round in 2019
Freemelt AB is a Swedish company founded in 2017 and based in Mölndal, specializing in the development and manufacturing of metal 3D printers. Its flagship product, the Freemelt One, utilizes electron beam melting (EBM) technology and is designed to facilitate materials innovation in additive manufacturing. Freemelt stands out by offering an open-source platform that allows customers to create and test their own materials, including OFHC copper, intermetallics, steels, and nickel-based superalloys. The company is involved in the marketing, sales, and servicing of the Freemelt One, targeting research institutions and industries focused on advanced materials development.

Ingrid Cloud

Venture Round in 2019
Ingrid Cloud AB is a Swedish company based in Stockholm that specializes in developing a cloud-based computational application for wind simulation. Established in 2014, the company offers a fully automated flow simulation service that enhances accuracy, flexibility, and cost efficiency for its users. Its platform simplifies the simulation process by automatically generating complex models from computer-aided design (CAD) geometry, allowing designers, engineers, researchers, and architects to conduct flow simulations without prior expertise in computational fluid dynamics (CFD). This accessibility empowers users to improve their design processes effectively and efficiently.

Crosser

Series A in 2019
Crosser is a technology company that specializes in streaming analytics and integration software, catering to edge, fog, and cloud computing environments. Its platform enables real-time processing of both streaming and batch data, facilitating data transformation, analytics, automation, and integration. By providing real-time analytics and decision-making capabilities akin to those of IoT sensors and devices, Crosser empowers enterprises in sectors such as healthcare, industrial IoT, and smart buildings. This functionality helps organizations minimize costs associated with cloud services and bandwidth, enhancing operational efficiency across various applications.

Athera Biotechnologies

Venture Round in 2019
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, specializing in the development of targeted anti-inflammatory therapeutics and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on addressing unmet medical needs in the prevention and treatment of CVD through innovative approaches. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as several biopharmaceutical candidates. Among these is PC-mAb, a monoclonal antibody therapy aimed at preventing the uptake of oxidized low-density lipoprotein in macrophages, and Annexin A5, which seeks to prevent plaque rupture and atherothrombotic events. Athera's research is rooted in advancements made at the Karolinska Institutet and reflects a commitment to harnessing scientific breakthroughs for improved patient outcomes in the realm of cardiovascular health.

NuvoAir Medical

Venture Round in 2019
NuvoAir AB, established in 2015 and headquartered in Stockholm, Sweden, specializes in remote patient monitoring for chronic heart and lung conditions. The company's core product is Air Next, a home spirometer that tracks lung function. NuvoAir's innovative platform combines this advanced monitoring technology with personalized care from a multidisciplinary team, including pulmonologists and cardiologists. By collaborating with health plans and risk-bearing entities, NuvoAir offers a value-based care model that aims to reduce healthcare costs and improve patient outcomes.

Gesynta Pharma

Seed Round in 2019
Gesynta Pharma AB is a clinical-stage pharmaceutical company based in Stockholm, Sweden, founded in 2017. The company focuses on developing compounds that inhibit the pro-inflammatory enzyme microsomal prostaglandin E synthase-1 (mPGES-1) to address chronic inflammatory conditions, particularly in cardiovascular diseases and cancer. Its most advanced drug candidate, vipoglanstat (GS-248), is being developed as a non-hormonal treatment for endometriosis, a painful condition affecting around 10 percent of women of reproductive age. Clinical studies have indicated that vipoglanstat significantly reduces endometriotic lesions and provides pain relief, with preparations underway for a phase II clinical trial. Additionally, Gesynta Pharma is advancing another candidate, GS-073, which is set to enter phase I clinical trials for a different inflammatory condition. The company's research is rooted in work from the Karolinska Institutet, and it aims to deliver safe and effective treatments for serious diseases.

Funnel

Venture Round in 2019
Funnel is a software company that specializes in marketing analytics and reporting tools designed to streamline data collection for online advertisers and e-commerce businesses. Founded in 2014 by Fredrik Skantze and Per Made, the company is headquartered in Stockholm and has an office in Boston. Funnel offers a platform that integrates seamlessly with over 400 marketing and advertising data sources, enabling users to automate the collection and organization of their advertising performance data. This integration allows businesses to easily transfer their data into various tools, such as Business Intelligence platforms, Data Warehouses, Google Sheets, and visualization tools. By providing a comprehensive overview of advertising expenditures and performance, Funnel helps businesses, including e-commerce companies, media agencies, B2B enterprises, mobile applications, and gaming firms, make informed decisions and predict future growth.

Formulate

Venture Round in 2018
Formulate AB operates a marketing analytics platform that assists retail merchandising teams in optimizing promotional performance. Founded in 2015 and based in Stockholm, Sweden, the company provides a cloud-based solution known as Formulate Decision Cloud, which leverages an advanced AI engine to transform sales data into actionable insights. By processing large volumes of business data, the platform offers analytics and competitive intelligence that facilitate better decision-making in campaign management. Additionally, the tool True Lift is designed to enhance the understanding of marketing outcomes, enabling retailers to analyze and forecast the effectiveness of their promotions.

Apica

Series D in 2018
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

DPOrganizer

Series A in 2018
DPOrganizer is a privacy management software company founded in 2015 and based in Stockholm, Sweden. It provides tools that enable organizations to map, visualize, report, and manage the processing of personal data, which is essential for compliance with data protection regulations such as GDPR. The software aims to give businesses better control over their handling of customer and employee personal information, thereby improving compliance and reducing risks. By streamlining the privacy program lifecycle, DPOrganizer enhances collaboration and communication within organizations, promoting efficient use of resources as they navigate privacy challenges.

Trialbee

Venture Round in 2018
Trialbee AB is an independent software company based in Malmö, Sweden, established in 2010. It specializes in developing a software-as-a-service solution aimed at enhancing patient matching and engagement in clinical trials. The company's platform facilitates patient recruitment, enrollment, and retention by providing various services such as resource libraries, adherence reminders, and comprehensive patient journey management. Trialbee's technology enables candidates to search for clinical trials and offers pre-screening and analysis tools, thus simplifying the clinical research process. The company serves a range of clients, including pharmaceutical sponsors, contract research organizations (CROs), investigator sites, and patients, with the goal of accelerating drug development through improved recruitment accuracy and efficiency.

Fishbrain

Series B in 2018
FishBrain AB, established in 2009 and headquartered in Stockholm, Sweden, develops a mobile application that serves as a social network, commerce platform, and tool for sport fishing enthusiasts. The Fishbrain app connects anglers, enables users to track and share personal statistics, provides fishing forecasts, and offers an interactive map to discover new fishing spots and see real-time catch data. It also promotes responsible fishing practices, such as catch and release, and sustainable harvesting. The app is available on both the App Store and Google Play.

DPOrganizer

Series A in 2017
DPOrganizer is a privacy management software company founded in 2015 and based in Stockholm, Sweden. It provides tools that enable organizations to map, visualize, report, and manage the processing of personal data, which is essential for compliance with data protection regulations such as GDPR. The software aims to give businesses better control over their handling of customer and employee personal information, thereby improving compliance and reducing risks. By streamlining the privacy program lifecycle, DPOrganizer enhances collaboration and communication within organizations, promoting efficient use of resources as they navigate privacy challenges.

Barnebys

Venture Round in 2017
Barnebys is a leading global search service based in Stockholm, Sweden, founded in 2011. The company specializes in art, antiques, and collectibles, offering a comprehensive online platform that aggregates information from auction houses and dealers worldwide. With a presence in key markets, including New York, the UK, France, Spain, and Germany, Barnebys serves a diverse clientele, ranging from prestigious auctioneers and antique dealers to regional businesses. The platform facilitates online transactions and provides users with tools to navigate the auction industry effectively. Additionally, Barnebys maintains an extensive free database of auction results and offers a premium valuation service, further enhancing its value proposition for buyers and sellers in the art and collectibles market.

Adfenix

Series A in 2017
Adfenix AB is a Swedish company founded in 2014 and headquartered in Gothenburg. It specializes in developing a social media advertising platform tailored for real estate agents, enabling them to attract new customers through targeted advertising. The Adfenix platform leverages real estate data to empower agents, enhancing their ability to assist consumers in the home-buying journey. By providing quality advertising products and related services, Adfenix simplifies the marketing process for real estate professionals, allowing them to engage effectively with potential clients.

Funnel

Series A in 2017
Funnel is a software company that specializes in marketing analytics and reporting tools designed to streamline data collection for online advertisers and e-commerce businesses. Founded in 2014 by Fredrik Skantze and Per Made, the company is headquartered in Stockholm and has an office in Boston. Funnel offers a platform that integrates seamlessly with over 400 marketing and advertising data sources, enabling users to automate the collection and organization of their advertising performance data. This integration allows businesses to easily transfer their data into various tools, such as Business Intelligence platforms, Data Warehouses, Google Sheets, and visualization tools. By providing a comprehensive overview of advertising expenditures and performance, Funnel helps businesses, including e-commerce companies, media agencies, B2B enterprises, mobile applications, and gaming firms, make informed decisions and predict future growth.

Starcounter

Venture Round in 2017
Starcounter, founded in 2006 by Joachim Wester, is a privately held company based in Stockholm, Sweden, with additional offices in Gdansk, Poland, and Palo Alto, USA. The company specializes in developing a database management platform that integrates in-memory computing and artificial intelligence technologies to enhance enterprise software systems. Starcounter's innovative platform combines a high-performance database engine with an application server, facilitating the creation of advanced business applications. With a research and development team comprising over 30 experts in mathematics, algorithms, and software development from seven different countries, Starcounter aims to improve the efficiency and performance of enterprise software applications, positioning itself as a leader in its field.

Fast Travel Games

Series A in 2017
Fast Travel Games, established in 2016 and based in Stockholm, Sweden, specializes in developing virtual reality games. Founded by industry veterans from studios like EA DICE, Rovio, and Avalanche, the company aims to create immersive gaming experiences that allow players to explore rich narratives and interact with others in innovative ways. Their games are designed to be played socially, supported by VR headsets, and are characterized by deep, engaging game universes.

Apica

Venture Round in 2017
Apica AB is a technology company based in Stockholm, Sweden, with additional offices in London, New York, and Santa Monica. Founded in 2005, it specializes in providing a load testing and synthetic monitoring platform tailored for enterprise needs. Apica's solutions encompass a range of applications, including internal systems, websites, mobile devices, and IoT use cases. The company's flagship products, Apica LoadTest and Apica Synthetic, ensure the performance and uptime of business-critical applications, allowing enterprises to prepare for peak conditions and proactively monitor their systems. Apica's unified platform simplifies data management, enabling real-time analysis of telemetry data and automated root cause analysis. Its tools facilitate efficient troubleshooting and enhance observability, making it easier for organizations to manage complex IT infrastructures while reducing costs and improving performance.

Athera Biotechnologies

Venture Round in 2017
Athera Biotechnologies AB is a biopharmaceutical company based in Stockholm, Sweden, specializing in the development of targeted anti-inflammatory therapeutics and companion diagnostics for cardiovascular diseases (CVD). Founded in 2002, the company focuses on addressing unmet medical needs in the prevention and treatment of CVD through innovative approaches. Its product portfolio includes CVDefine, an immunological marker and ELISA kit designed for cardiovascular risk assessment, as well as several biopharmaceutical candidates. Among these is PC-mAb, a monoclonal antibody therapy aimed at preventing the uptake of oxidized low-density lipoprotein in macrophages, and Annexin A5, which seeks to prevent plaque rupture and atherothrombotic events. Athera's research is rooted in advancements made at the Karolinska Institutet and reflects a commitment to harnessing scientific breakthroughs for improved patient outcomes in the realm of cardiovascular health.

InRiver

Venture Round in 2017
InRiver AB is a software company that specializes in product information management (PIM) solutions, designed to assist businesses in effectively managing and distributing product information across various sales channels. Founded in 2007 and headquartered in Malmö, Sweden, with regional offices in Chicago, Amsterdam, and Stockholm, InRiver caters to both B2C and B2B multi-channel commerce professionals. The company's platform enables organizations to create, maintain, and uniformly present product information, including sales materials like videos and images, in multiple languages. With a client base of over 1,000 brands across 19 countries, InRiver aims to enhance revenue, customer satisfaction, and brand equity by transforming product information into strategic assets. The company has also established a strategic partnership with Aprimo LLC, further extending its capabilities in the market.

Sol Voltaics

Series D in 2017
Sol Voltaics AB is a nanotechnology company based in Lund, Sweden, established in 2007. It specializes in enhancing the efficiency of solar energy capture and generation by utilizing innovative nanomaterials. The company's flagship product, SolFilm, is a solar panel additive composed of gallium arsenide nanowires that significantly boosts the performance of silicon solar modules. This lightweight photonic film not only converts high-energy sunlight into electricity but is also transparent to infrared light, allowing for further energy conversion by underlying CIGS or silicon cells in a stacked configuration. By integrating these technologies, Sol Voltaics aims to increase conventional photovoltaic module efficiencies by up to 50%, positioning itself at the forefront of the next generation of solar energy solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.